Humacyte, Inc. Pay versus Performance
The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.
- 2025-12-31: PEO Dr. Niklason; PEO total compensation $5.23M; PEO compensation actually paid -$725.03K; Other NEO average total compensation $2.11M.
- 2024-12-31: PEO total compensation $905.44K; PEO compensation actually paid $2.90M; Other NEO average total compensation $678.02K.
| Fiscal year end | PEO | PEO total compensation | PEO compensation actually paid | Other NEO average total compensation | Other NEO average compensation actually paid | Total shareholder return | Peer group total shareholder return | Net income | Company-selected measure | Proxy filed |
|---|
| 2025-12-31 | Dr. Niklason | $5.23M | -$725.03K | $2.11M | $298.37K | $33.80 | | -$40.83M | | 2026-04-28 |
|---|
| 2024-12-31 | | $905.44K | $2.90M | $678.02K | $1.44M | $177.82 | | -$148.70M | | 2026-04-28 |
|---|